Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Bresch low-balled her company’s profit on the EpiPen
News that Bresch low-balled her company’s profit on the EpiPen during her recent Congressional testimony could send the stock tumbling further over the next few days.
Bresch based her profit estimate on U.S. tax rates, but the company, whose main office is near Pittsburgh, is legally headquartered in the Netherlands after a 2015 tax inversion with Abbott Labs.
Mylan has been consolidating the generic drug market to get branded profit margins from those drugs, then shipping the profits overseas and avoiding taxes on them.
http://www.msn.com/en-us/money/companies/how-the-mylan-scandal-is-taking-down-generic-drugs/ar-BBwH4Pz?li=BBmkt5R&ocid=spartanntp
